Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Polynovo Ltd (ASX: PNV)
    3. /

Polynovo Ltd (ASX: PNV) Share Price and News

Price

$1.195

Movement

0.03 (+2.58%)

As at 27 Jun - Closed (20 mins delayed)

52 Week Range

$0.93 - $2.78

 
1 Year Return

-51.02%

Polynovo Ltd Chart and Price Data

$0
$1
$2
$3
$0
$1
$2
$3
$0
$1
$2
$3
$0
$1
$2
$3

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $825.56 million
P/E Ratio 142.26
Dividend Yield 0.00%
Shares Outstanding 690.84 million
Earnings per share 0.008
Dividend per share N/A
Year To Date Return -41.42%
Earnings Yield 0.70%
Franking -
Earnings Yield

0.70%

Franking

-

Dividend per share

N/A

Year To Date Return

-41.42%

Shares Outstanding

690.84 million

Earnings per share

0.008

Share Price

$1.195

Day Change

0.03 (+2.58%)

52 Week Range

$0.93 - $2.78

Yesterday's Close

$1.165

Today's Open

$1.19

Days Range

$1.18 - $1.215

Volume

1,811,218

Avg. Volume (1 month)

1,831,805

Turnover

$2,173,732

As at 27 Jun - Closed

    • Polynovo Ltd (ASX: PNV)
    Latest News

    A man holds his head in his hands, despairing at the bad result he's reading on his computer.
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    Person pretends to types on laptop drawn in sand.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a happy finish to the week for ASX shares this Friday.

    Read more »

    A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    Man on computer looking at graphs
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors were back to the races this hump day...

    Read more »

    A man in a suit face palms at the downturn happening with shares today.
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    Small chocolate bunnies.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors ended the short trading week on a high today.

    Read more »

    Person pretends to types on laptop drawn in sand.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors were off to a flying start this Monday.

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Share Fallers

    Why Mineral Resources, Polynovo, Regal Partners, and Santos shares are falling today

    | James Mickleboro

    These shares are having a tough time on hump day. But why?

    Read more »

    Stock market chart in green with a rising arrow symbolising a rising share price.
    Share Gainers

    Here are the ASX 200 shares leading Tuesday's market rebound

    | Bronwyn Allen

    The Australian share market is in the green as investors look for opportunities after yesterday's 4.23% plunge.

    Read more »

    A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
    Share Fallers

    These were the worst ASX 200 shares to own in Q1 2025

    | James Mickleboro

    Let's see why investors were selling off these shares during the first quarter.

    Read more »

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    Healthcare Shares

    Bell Potter says this ASX 200 share can rise 120%

    | James Mickleboro

    Let's see what the broker is saying about this beaten down stock.

    Read more »

    A bored woman looking at her computer, it's bad news.
    Share Fallers

    Why Brickworks, Nickel Industries, Polynovo, and Qantas shares are sinking today

    | James Mickleboro

    These shares are having a difficult time on Tuesday. But why?

    Read more »

    Frequently Asked Questions

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    21st May 2025 2025-05-21T16:21:40 Becoming a substantial holderYesNo4:21pm17695k
    16th May 2025 2025-05-16T15:06:39 Webcast Recording - Investor UpdateYesNo3:06pm1227k
    16th May 2025 2025-05-16T08:23:27 Investor Presentation & Webcast LinkYesNo8:23am7799k
    13th May 2025 2025-05-13T13:26:35 BTM delivers positive First in Man results in Cell TherapiesYesNo1:26pm4391k
    12th May 2025 2025-05-12T16:18:47 Trading HaltYesNo4:18pm2263k
    12th May 2025 2025-05-12T14:44:07 TGA Clearance for NovoSorb MTX (4 mm and 6 mm)YesNo2:44pm2226k
    7th May 2025 2025-05-07T13:28:14 PolyNovo presents at Macquarie Australia ConferenceYesNo1:28pm91.7M
    1st May 2025 2025-05-01T16:46:02 Investor Update Webinar - 16 May 2025YesNo4:46pm2279k
    22nd Apr 2025 2025-04-22T15:16:01 Change in substantial holdingYesNo3:16pm252.3M
    22nd Apr 2025 2025-04-22T08:21:59 Change in substantial holdingYesNo8:21am251.7M

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Jun 2025 $1.20 $0.03 2.58% 1,811,218 $1.19 $1.22 $1.18
    26 Jun 2025 $1.17 $-0.01 -0.85% 1,970,582 $1.18 $1.20 $1.16
    25 Jun 2025 $1.18 $-0.03 -2.49% 2,265,072 $1.21 $1.25 $1.17
    24 Jun 2025 $1.21 $0.02 1.69% 1,719,145 $1.18 $1.23 $1.17
    23 Jun 2025 $1.19 $-0.03 -2.46% 1,408,423 $1.19 $1.20 $1.15
    20 Jun 2025 $1.22 $0.01 0.83% 2,146,159 $1.20 $1.22 $1.19
    19 Jun 2025 $1.21 $0.00 0.00% 1,642,776 $1.21 $1.22 $1.19
    18 Jun 2025 $1.21 $-0.01 -0.82% 1,676,203 $1.22 $1.22 $1.19
    17 Jun 2025 $1.22 $0.00 0.00% 1,476,249 $1.22 $1.25 $1.21
    16 Jun 2025 $1.22 $0.04 3.39% 2,065,387 $1.16 $1.23 $1.15
    13 Jun 2025 $1.18 $-0.09 -7.11% 3,105,313 $1.27 $1.27 $1.16
    12 Jun 2025 $1.27 $-0.04 -3.07% 2,335,785 $1.30 $1.30 $1.26
    11 Jun 2025 $1.31 $-0.04 -2.97% 2,589,203 $1.36 $1.38 $1.30
    10 Jun 2025 $1.35 $0.03 2.29% 1,829,089 $1.31 $1.35 $1.30
    06 Jun 2025 $1.31 $-0.03 -2.24% 1,082,756 $1.36 $1.36 $1.30
    05 Jun 2025 $1.34 $0.03 2.28% 2,733,737 $1.32 $1.37 $1.32
    04 Jun 2025 $1.32 $0.05 3.95% 1,389,990 $1.28 $1.34 $1.28
    03 Jun 2025 $1.27 $0.00 0.00% 1,023,591 $1.27 $1.28 $1.25
    02 Jun 2025 $1.26 $-0.05 -3.82% 1,312,053 $1.32 $1.33 $1.26
    30 May 2025 $1.31 $0.01 0.77% 1,742,811 $1.30 $1.33 $1.28
    29 May 2025 $1.31 $0.01 0.78% 740,284 $1.29 $1.32 $1.29

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 Jan 2025 David Williams Sell 750 $1,522
    Off-market trade.
    30 Sep 2024 Andrew Lumsden Sell 50,000 $130,915
    On-market trade.
    26 Sep 2024 Leon Hoare Sell 100,000 $260,839
    On-market trade. As per announcement on 02-01-2024
    13 Sep 2024 Bruce Rathie Sell 750,000 $1,886,900
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams is a director and investment banker with a track record in business development, mergers and acquisitions, and capital raising. He has experience advising companies in the food, medical device, and pharmaceutical sectors. Mr Williams is currently Managing Director of corporate advisory firm Kidder Williams.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott has a track record in product development, clinical trials, regulatory affairs, audits, quality management, project management and operational strategy. Her worldwide experience in new facility delivery, production scale up, strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally. Dr Elliott was Global Head, Strategic Portfolio Management at CSL Behring, a role that is responsible for governance oversight and business value delivery. Dr Elliott is a member of the Risk Committee.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden has more than 20 years of experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer. Prior to joining Wellcom, Mr Lumsden was a Senior Manager within the Audit and Assurance practice of PricewaterhouseCoopers. Mr Lumsden is the Chair of the Risk Committee.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare has expertise across multiple Life Sciences sectors. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew (S&N) ANZ. He served as President of S&N's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly is an IP and business development professional with more than 30 years of local and international experience. She has been on the Board of the Institute of Patent and Trademark Attorneys of Australia for over a decade. Ms Emmanuel-Donnelly was Executive Manager of Business Development and Commercial at the CSIRO, was in-house IP Counsel for Unilever in the U.K., and practiced as a patent and trademark attorney for Wilson Gunn.
    Mr Jan-Marcel Gielen Company Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan Gielen Chief Financial Officer
    -
    Philip Scorgie Chief Information Officer
    -
    Joseph Amaral Chief Medical Officer (part-time)
    -
    Ingrid Anderson Chief People Officer
    -
    David McQuillan Chief Technical and Scientific Officer
    -
    Jan-Marcel Gielen Company Secretary
    -
    David Morris President Asia Pacific
    -
    Edward Graubart President North America
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 96,149,727 13.93%
    J P Morgan Nominees Australia Pty Limited 80,078,534 11.60%
    Citicorp Nominees Pty Limited 37,720,578 5.46%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    Lateral Innovations Pty Ltd (Trust A/C 10,924,103 1.58%
    Mr Anthony Shane Kittel Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,050,000 1.17%
    Bnp Paribas Noms Pty Ltd 7,622,413 1.10%
    National Nominees Limited 6,653,041 0.96%
    Netwealth Investments Limited (Wrap Services A/C) 5,394,880 0.74%
    BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient) 4,533,452 0.66%
    BNP Paribas Nominees Pty Ltd (Agency Lending A/C) 4,414,903 0.64%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mrs Li-Hsien Tsai 3,955,424 0.57%
    Mr David Kenley 3,755,000 0.54%
    Mr Paul Gerard Brennan 3,569,796 0.52%
    Mr Matthew James Avery 3,439,332 0.50%
    Mr David Kenley i 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Evan Philip Clucas Ms Leanne Jane Weston (Kuranga Nursery Super A/C) 2,931,149 0.42%
    Mr Chris Dawborn (Haskali Super Fund A/C) 2,870,271 0.42%

    Profile

    since

    Note